This year’s agenda features deep technical and project-level insight from experienced practitioners who work at the intersection of facility design, sustainability, commissioning, qualification, and risk management. Presentations by Thomas Centner, PhD, Principal Consultant with Io-consultants GmbH & Co. KG, and Bruce Klopfenstein, Commissioning, Qualification, and Validation (CQV) PM with GSK, exemplify this approach, drawing on real projects and proven methodologies to address two critical questions facing the industry today: how to design truly sustainable GMP facilities, and how to prevent avoidable risk by engaging CQV earlier in the project lifecycle.
Designing GMP Facilities for a Sustainable Future
Sustainability is increasingly shaping how pharmaceutical and medtech facilities are conceived, designed, and operated, especially within highly regulated environments where quality expectations remain uncompromising.
In his session, Thomas Centner, PhD, explores sustainability through the lens of the Erbe 4.i project, a facility designed to carry sustainability principles from early vision through full GMP operation. Centner’s session centers on a bold but carefully executed concept: delivering a GMP‑compliant cleanroom environment within a timber‑structure building. Timber construction is rarely associated with classified pharmaceutical spaces, yet the Erbe 4.i project demonstrates how alternative building materials can be successfully integrated into regulated manufacturing when supported by sound engineering and contamination control strategies.
The presentation examines the properties that make timber an increasingly compelling choice for future facilities, including its low embodied carbon, lightweight structure, spanning capability, local availability, and recyclability. Centner outlines how these benefits were evaluated and balanced against cleanroom performance requirements and regulatory expectations, resulting in a manufacturing environment that meets GMP standards without defaulting to traditional construction assumptions.
Sustainability considerations extended well beyond structural design. A key element of the Erbe 4.i concept was the pursuit of exceptional energy efficiency within an active manufacturing environment. The project includes a 5,500‑square‑meter photovoltaic installation, integrated into a broader servicing strategy aimed at minimizing energy consumption and environmental impact. The result is a production facility with one of the highest documented energy‑saving profiles for pharmaceutical and medtech operations in Europe and globally. The project received 2025 ISPE Facility of the Year Awards (FOYA) Category Winner – Honorable Mention recognition.
Rather than positioning sustainability as a constraint, the session frames it as a design driver supporting long-term operational resilience and efficiency. By tracing the project from concept through GMP operation, Centner provides a tangible benchmark for organizations seeking to align environmental responsibility with regulatory compliance and manufacturing performance.
Shifting Risk Left: Early CQV as a Leadership Function
Commissioning and qualification represent a pivotal point at which design intent, execution discipline, and operational readiness are brought together. In his session, Bruce Klopfenstein examines how the clarity—or lack thereof—seen during commissioning and qualification (C&Q) reflects decisions made much earlier in the project lifecycle. The discussion centers on how early CQV engagement enables teams to address those decisions sooner, improving outcomes across design, delivery, and GMP compliance.
His session challenges the traditional sequencing of CQV activities, presenting an approach in which commissioning, qualification, and validation take on a leadership role early in the project lifecycle. Beginning at the basis of design and extending through detailed design, the model reshapes CQV as a proactive discipline focused on early alignment, risk identification, and informed decision-making.
Drawing on practical project experience, Klopfenstein walks through a five‑phase early CQV engagement framework that can be applied as soon as design intent begins to take shape. The approach emphasizes collaboration across engineering, quality, and operations, enabling teams to surface and address potential qualification issues before they become execution challenges.
The session also introduces an early CQV toolkit designed to support consistent implementation. This toolkit includes planning templates, structured forms, early risk identification tools, and AI prompt sets that assist with documentation quality, evaluations, and alignment during early project phases. Rather than adding complexity, these tools are positioned as enablers for clarity and consistency when decisions have the greatest impact.
A core message of the session is that early CQV engagement is not additional work layered onto a project. Instead, it functions as risk control for the entire delivery lifecycle, reducing rework, avoiding late-stage surprises, and protecting GMP compliance. By shifting effort to earlier phases, projects can achieve greater predictability and more efficient execution.
A Conference Focused on Practical Progress
The 2026 ISPE Europe Annual Conference is designed to support informed decision‑making across the full pharmaceutical lifecycle—from early facility concept through operational readiness. Hosting the event in Copenhagen underscores the conference’s emphasis on sustainability, efficiency, and future‑focused thinking within regulated manufacturing.
Sessions such as those led by Thomas Centner and Bruce Klopfenstein reflect the broader intent of the conference: sharing insight grounded in real facilities, real projects, and real constraints. By focusing on sustainable design strategies and disciplined early engagement, the program highlights how progress in pharmaceutical manufacturing is driven not only by new ideas, but by structured execution and cross‑functional alignment.
As the industry continues to adapt to evolving regulatory, environmental, and operational expectations, the discussions taking place in Copenhagen will help shape how facilities are designed, projects are delivered, and quality is maintained in the years ahead.
Learn more and register today
